Investment in companies in the field of life sciences and healthcare in Catalonia grew to €112M in 2019 Blog Post

Life sciences and healthcare start-ups and companies in Catalonia managed to attract €112M of investment in 2019, a figure that has remained stable for four years in a row and is 3% higher than in 2018, according to the study presented today by CataloniaBio & HealthTech and Biocat –based in the Barcelona Science Park– jointly with and EY. Investors and experts predict that in 2020 this will reach a record figure, boosted by an interest in the sector after Covid-19.


Promoting scientific careers in times of COVID-19 Blog Post

Against the backdrop of the major challenges posed by the COVID-19 pandemic, which has underscored the crucial role science and technology play in our society, the Barcelona Science Park is stepping up its commitment to persuading young people to choose scientific careers by holding a new edition of Batx2Lab, a pioneering programme which has inspired the STEM talent of more than 700 young people.


Vice-president Pere Aragonès meets with stakeholders, companies and investors in the healthcare and life sciences sector Blog Post

Vice-president of the Government of Catalonia Pere Aragonès and Director General for Research and Innovation in Health Robert Fabregat visited the Barcelona Science Park (PCB) yesterday, where they met with Biocat, CataloniaBio & HealthTech, start-ups and investors to learn about the healthcare and life sciences sector’s potential as a driving force for Catalan innovation and competitiveness after the Covid-19 pandemic.


Gorka Etxebarria, new Chief Scientific Officer of Nostrum Biodiscovery Blog Post

Nostrum Biodiscovery (NBD) has appointed Dr. Gorka Etxebarria as new Chief Scientific Officer. Dr Etxebarria has a solid career linked to drug discovery projects in the pharmaceutical industry. His incorporation comes after the signing of Ezequiel Mas as new company CEO, to pilot a new stage of growth as a global provider of leading molecular simulation technologies applied to drug discovery and design.


Oxolife raises €5 million in a funding round and joins the Barcelona Science Park Blog Post

The biotech Oxolife –focused on the development of a new treatment to improve the female fertility rate– has moved its headquarters to the Barcelona Science Park. The company, which has just raised a €5 million funding round, will start a phase II clinical trial to evaluate the efficacy of OXO-001, a drug that specifically acts on embryo implantation to increase pregnancy success rate in assisted reproductive technology processes.


Genesis Biomed launches the startup Everai Medical Technologies Blog Post

Genesis Biomed, based in the Barcelona Science Park, has just founded Everai Medical Technologies, a startup that focused its activity on developing software that will make it possible to share patient data between the ambulance doctor and the hospital’s emergency personnel. The company was born as a project supported by EIT Digital and the involvement of the Belgian hub Interuniversity Microelectronics Center (IMEC) and the Dutch company Pipple.


Scientists at CNAG-CRG and CRG develop a new tool to film genome dynamics Blog Post

Scientists from the Centro Nacional de Análisis Genómico (CNAG-CRG) –based in the Barcelona Science Park and integrated into the Centre for Genomic Regulation (CRG)– have developed TADdyn, a tool that can generate movies of how genomes change over time. The finding, published in Nature Communications, will help researchers worldwide learn much more about the direct relationship between structure and function in the genome.